What can we learn from the implementation of a novel point-of-care Antigen-Based SARS-CoV-2 Rapid Diagnostic Test to Screen Incoming Patients in a large University Hospital? (COVID-19)

• Conditions: COVID-19

• Registration Number: DRKS00023584
• Lead Sponsor: niversitätsklinikum Heidelberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-17
• Study Completion: 2021-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

18 years or older; capable to give informed consent, having signed informed consent.
For heads of departments: Head of a department at UKHD currently employing a RDT-based COVID-19 testing strategy following the task-forces recommendation.
For practitioners: Medical practitioner (e.g. nurses, medical doctors) responsible for performing RDTs with patients at a clinic within UKHD.
For Patients: Patient admitted for elective care, emergency care, or outpatient treatment to a clinic within UKHD and having been tested for COVID-19 using a RDT.
Heads of non/late-implementing department: Head of a department at UKHD currently not employing a RDT-based COVID-19 testing strategy following the task-forces recommendation.
Task-Force Members: Member of the COVID-19 task force at UKHD involved in preparing the recommendation with regards to COVID-19 RDTs
Trainers: Individual responsible for capacity building for and implementation of RDT testing strategies at UKHD.

Exclusion Criteria

Refusing or withdrawing informed consent; Incapacitated persons (mentally challenged; physical disability – i.e. hearing and speech impaired; totally blind)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Analysis of the implementation of the AG-RDTs at UKHD (fidelity, adoption, adaptation), based on the interviews, observations, and diagnostic yield data described above.

Secondary Outcome Measures

Name	Time	Method
Recommendations for future implementation of AG-RDT-based testing strategies in high-risk settings, based on the collected data (Interviews, observations, data on diagnostic yield).